Skip to main content

Advertisement

Log in

Efficacy of oral adsorbent for treatment of peristomal fistula associated with Crohn's disease

  • Case report
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract:

Perianal fistulae are frequently seen complications in Crohn's disease. Although surgical procedures such as Seton's method have been devised, many patients still suffer from fistulae that are resistant to conventional therapy. We administreved oral adsorbent to a patient with disease Crohn's who had a complicated peristomal fistula that did not improve with conventional therapy. Six grams of oral adsorbent (AST-120) were added daily to a regimen of elemental diet therapy and prednisolone. The fistula gradually decreased in size after the administration of the oral adsorbent, and had healed completely after 40 days' treatment. There were no side effects from the oral adsorbent. This case report suggests that oral adsorbent is an effective treatment for peristomal fistula associated with Crohn's disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: March 31, 1999 / Accepted: August 27, 1999

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tsujikawa, T., Araki, Y., Makino, J. et al. Efficacy of oral adsorbent for treatment of peristomal fistula associated with Crohn's disease. J Gastroenterol 35, 296–298 (2000). https://doi.org/10.1007/s005350050349

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s005350050349

Navigation